CCI approves P&G's acquisition of 51.80% stake in drug firm Merck Ltd

The global deal will be executed through the sale of Merck's shares in a number of legal entities as well as various asset sales and comprises the consumer health business across 44 countries

merck
Photo: Reuters
Press Trust of India New Delhi
Last Updated : Aug 07 2018 | 9:24 PM IST

The Competition Commission has approved Procter & Gamble's acquisition of 51.80 per cent stake in drug firm Merck Ltd, which is listed on the Indian bourses.

The acquisition of 51.80 per cent stake in Merck Ltd by P&G for nearly Rs 12.9 billion is part of a global deal under which the latter is taking over German firm Merck KGaA's international consumer health business.

The global deal is for about 3.4 billion euro in cash.

In a tweet on Tuesday, the Competition Commission of India (CCI) said it has approved acquisition of 51.80 per cent stake by P&G in consumer health business of Merck Ltd.

The stake acquisition will be through Procter & Gamble Overseas India BV, an investment holding company held ultimately by P&G.

According to the notice submitted to the CCI, P&G had proposed to acquire the consumer health business of Merck KGaA globally, pursuant to a sale and purchase agreement dated April 19, 2018 (Global SAPA). As part of the agreement, P&G had also offered to buy the consumer health business of Merck Specialities.
 

Separately, following another sale and purchase agreement dated April 19, 2018 (India SAPA), Procter & Gamble Overseas India BV had proposed to acquire 51.80 per cent shares in Merck Ltd, as per the notice.

The global deal will be executed through the sale of Merck's shares in a number of legal entities as well as various asset sales and comprises the consumer health business across 44 countries, including more than 900 products and two consumer health-managed production sites in Spittal (Austria) and Goa (India).

The transaction is expected to close by the year end. JP Morgan acted as financial adviser to Merck on the transaction, while Freshfields Bruckhaus Deringer acted as its legal adviser.
 

The Competition Commission has also approved Singapore-based investment fund TPG Asia VII SF's stake acquisition in RR Kabel and Ram Ratna Electricals.

"@CCI_India approves acquisition of ~21 per cent stake in each RR Kabel and Ram Ratna Electricals by TPG Asia," the CCI said in a tweet.

RR Kabel manufactures wires and cables while Ram Ratna Electricals is the consumer electricals and appliances arm of RR Global Group.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 07 2018 | 8:35 PM IST

Next Story